latest news

ChromaCure raises €17M for its drug discovery program

ChromaCure is a newly created spin-off company of ULB dedicated to develop first-in-class small molecule therapeutics for unmet needs in oncology, based on a very promising target. We are delighted to welcome them in our incubator. Discover the official press release here.